Advertisement
Research Article

Trypanosoma cruzi CYP51 Inhibitor Derived from a Mycobacterium tuberculosis Screen Hit

  • Chiung-Kuang Chen,

    Affiliation: Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States of America

    X
  • Patricia S. Doyle,

    Affiliation: Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America

    X
  • Liudmila V. Yermalitskaya,

    Affiliation: Department of Pharmacology, Vanderbilt University, Nashville, Tennessee, United States of America

    X
  • Zachary B. Mackey,

    Affiliation: Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America

    X
  • Kenny K. H. Ang,

    Affiliation: Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America

    X
  • James H. McKerrow,

    Affiliation: Sandler Center for Basic Research in Parasitic Diseases, University of California, San Francisco, California, United States of America

    X
  • Larissa M. Podust mail

    larissa.podust@ucsf.edu

    Affiliation: Department of Pharmaceutical Chemistry, University of California, San Francisco, California, United States of America

    X
  • Published: February 03, 2009
  • DOI: 10.1371/journal.pntd.0000372

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.